Article (Scientific journals)
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.
Task Force for the management of COVID-19 of the European Society of Cardiology; LANCELLOTTI, Patrizio
2022In European Heart Journal, 43 (11), p. 1033-1058
Peer Reviewed verified by ORBi
 

Files


Full Text
ehab696.pdf
Author postprint (6.51 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
ACE2; Arrhythmias; Biomarkers; COVID-19; Cardiogenic shock; Myocardial injury; Myocarditis; Non-invasive imaging; Humans; Pandemics; Prospective Studies; Cardiology; Cardiovascular Diseases/diagnosis; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/therapy; Cardiovascular Diseases; Cardiology and Cardiovascular Medicine
Abstract :
[en] AIMS: Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19. METHODS AND RESULTS: A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19. CONCLUSION: This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Task Force for the management of COVID-19 of the European Society of Cardiology
LANCELLOTTI, Patrizio  ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie
Language :
English
Title :
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis.
Publication date :
14 March 2022
Journal title :
European Heart Journal
ISSN :
0195-668X
eISSN :
1522-9645
Publisher :
NLM (Medline), England
Volume :
43
Issue :
11
Pages :
1033-1058
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 17 May 2022

Statistics


Number of views
118 (2 by ULiège)
Number of downloads
65 (1 by ULiège)

Scopus citations®
 
80
Scopus citations®
without self-citations
71
OpenCitations
 
27

Bibliography


Similar publications



Contact ORBi